Cargando…

Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation

BACKGROUND: Type 2 Diabetes mellitus (T2DM) is a common comorbidity in patients after heart transplantation (HTx) and is associated with adverse long-term outcomes. METHODS: The retrospective study reported here analyzed the effects of vildagliptin therapy in stable patients post-HTx with T2DM and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gueler, Ibrahim, Mueller, Susanne, Helmschrott, Matthias, Oeing, Christian U, Erbel, Christian, Frankenstein, Lutz, Gleißner, Christian, Ruhparwar, Arjang, Ehlermann, Philipp, Dengler, Thomas J, Katus, Hugo A, Doesch, Andreas O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623547/ https://www.ncbi.nlm.nih.gov/pubmed/23630415 http://dx.doi.org/10.2147/DDDT.S43092

Ejemplares similares

Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study
por: Doesch, Andreas O, et al.
Publicado: (2013)

Conversion to generic cyclosporine A in stable chronic patients after heart transplantation
por: Kraeuter, Maximilian, et al.
Publicado: (2013)

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation
por: Doesch, Andreas O, et al.
Publicado: (2013)

Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation
por: Helmschrott, Matthias, et al.
Publicado: (2015)

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
por: Doesch, Andreas O, et al.
Publicado: (2012)

Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy
por: Rivinius, Rasmus, et al.
Publicado: (2014)

Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2016)

Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen
por: Helmschrott, Matthias, et al.
Publicado: (2014)

The influence of surgical technique on early posttransplant atrial fibrillation – comparison of biatrial, bicaval, and total orthotopic heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2017)

COPD in patients after heart transplantation is associated with a prolonged hospital stay, early posttransplant atrial fibrillation, and impaired posttransplant survival
por: Rivinius, Rasmus, et al.
Publicado: (2018)

Elevated pre‐transplant pulmonary vascular resistance is associated with early post‐transplant atrial fibrillation and mortality
por: Rivinius, Rasmus, et al.
Publicado: (2020)

Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality
por: Rivinius, Rasmus, et al.
Publicado: (2017)

Inhibition of B7-1 (CD80) by RhuDex(®) reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions
por: Doesch, Andreas O, et al.
Publicado: (2014)

Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2017)

Constrictive Pericarditis in the Presence of Remaining Remnants of a Left Ventricular Assist Device in a Heart Transplanted Patient
por: Rivinius, R., et al.
Publicado: (2015)

CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions
por: Akhavanpoor, Mohammadreza, et al.
Publicado: (2014)

Adventitial inflammation and its interaction with intimal atherosclerotic lesions
por: Akhavanpoor, Mohammadreza, et al.
Publicado: (2014)

Correction to: Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2021)

Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2020)

Combined amiodarone and digitalis therapy before heart transplantation is associated with increased post‐transplant mortality
por: Rivinius, Rasmus, et al.
Publicado: (2020)

CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque Morphology
por: Erbel, Christian, et al.
Publicado: (2015)

Inflammatory therapeutic targets in coronary atherosclerosis—from molecular biology to clinical application
por: Linden, Fabian, et al.
Publicado: (2014)

Transfemoral aortic valve replacement for severe aortic valve regurgitation in a patient with a pulsatile‐flow biventricular assist device
por: Gomes, Bruna, et al.
Publicado: (2018)

Systematic RNA-interference in primary human monocyte-derived macrophages: A high-throughput platform to study foam cell formation
por: Domschke, Gabriele, et al.
Publicado: (2018)

Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy
por: Helmschrott, Matthias, et al.
Publicado: (2017)

Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis
por: Franke, Jennifer, et al.
Publicado: (2011)

Haemodynamic effects of percutaneous mitral valve edge‐to‐edge repair in patients with end‐stage heart failure awaiting heart transplantation
por: Geis, Nicolas A., et al.
Publicado: (2018)

Etiology-specific assessment of predictors of long-term survival in chronic systolic heart failure
por: Franke, Jennifer, et al.
Publicado: (2015)

PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels
por: Erbel, C, et al.
Publicado: (2011)

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
por: Das, Sambit, et al.
Publicado: (2021)

The need for dedicated advanced heart failure units to optimize heart failure care: impact of optimized advanced heart failure unit care on heart transplant outcome in high‐risk patients
por: Kreusser, Michael M., et al.
Publicado: (2018)

Prognostic value of myocardial strain analysis with cardiac magnetic resonance in patients with dilated cardiomyopathy
por: Buss, Sebastian, et al.
Publicado: (2014)

Identification of Specific Coronary Artery Disease Phenotypes Implicating Differential Pathophysiologies
por: Krohn, Jona B., et al.
Publicado: (2022)

Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation
por: Heil, Karsten M., et al.
Publicado: (2021)

Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification
por: Korosoglou, Grigorios, et al.
Publicado: (2014)

The potential role of vildagliptin in the management and prevention of type 2 diabetes mellitus
por: Chakraborti, C.K.
Publicado: (2008)

Vildagliptin: a new oral treatment for type 2 diabetes mellitus
por: Mathieu, Chantal, et al.
Publicado: (2008)

Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
por: Profit, Louise, et al.
Publicado: (2008)

Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study
por: Van Gaal, Luc, et al.
Publicado: (2019)

Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy?
por: Riffel, Johannes H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eebe6k46fac3u4vjbq6qov1op4